发明名称 |
OCULAR COMPOSITION AND METHOD |
摘要 |
An ocular composition can include a polymer matrix and an antibiotic dispersed in the polymer matrix. The polymer matrix can contain a thiolated hyaluronic acid moiety cross-linked to a second moiety. The composition can be configured for placement in or on an eye of a subject to provide controlled release of the antibiotic to the eye. A method of treating or preventing an ocular disease can include providing an ocular composition and applying the ocular composition to a surface of an eye of a subject to provide controlled release of the antibiotic to the eye. The ocular composition can include a polymer matrix and an antibiotic dispersed in the polymer matrix. The polymer matrix can include a thiolated hyaluronic acid moiety cross-linked to a second moiety. |
申请公布号 |
US2015157563(A1) |
申请公布日期 |
2015.06.11 |
申请号 |
US201414584787 |
申请日期 |
2014.12.29 |
申请人 |
Jade Therapeutics, Inc |
发明人 |
Wirostko Barbara |
分类号 |
A61K9/00;A61K9/70;A61K45/06;A61K31/7036;A61K31/407;A61K31/522;A61K31/5575;A61K31/4709;A61K47/36 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. An ocular composition, comprising:
a polymer matrix comprising a thiolated hyaluronic acid moiety cross-linked to a second moiety; and an antimicrobial dispersed in the polymer matrix at a dosage sufficient to inhibit microbial growth; wherein the composition is configured for placement in or on an eye of a subject, and wherein the composition provides controlled release of an amount of the antimicrobial to the eye. |
地址 |
Salt Lake City UT US |